These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16306604)

  • 41. Sequences in the hypervariable region 1 of hepatitis C virus show only minimal variability in the presence of antibodies against hypervariable region 1 during acute infection in chimpanzees.
    Zhou YH; Sugitani M; Esumi M
    Arch Virol; 2002 Oct; 147(10):1955-62. PubMed ID: 12376756
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in neutralization sensitivity.
    Prentoe J; Velázquez-Moctezuma R; Foung SK; Law M; Bukh J
    Hepatology; 2016 Dec; 64(6):1881-1892. PubMed ID: 27351277
    [TBL] [Abstract][Full Text] [Related]  

  • 43. E2 quasispecies specificity of hepatitis C virus association with allografts immediately after liver transplantation.
    Hughes MG; Rudy CK; Chong TW; Smith RL; Evans HL; Iezzoni JC; Sawyer RG; Pruett TL
    Liver Transpl; 2004 Feb; 10(2):208-16. PubMed ID: 14762858
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Sequence diversity and variability in the putative envelope proteins including hypervariable regions of hepatitis C virus].
    Nakazawa T; Hijikata M; Kato N; Shimotohno K
    Nihon Rinsho; 1993 Feb; 51(2):318-22. PubMed ID: 8385235
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding.
    Owsianka AM; Timms JM; Tarr AW; Brown RJ; Hickling TP; Szwejk A; Bienkowska-Szewczyk K; Thomson BJ; Patel AH; Ball JK
    J Virol; 2006 Sep; 80(17):8695-704. PubMed ID: 16912317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Scavenger receptor class B type I and the hypervariable region-1 of hepatitis C virus in cell entry and neutralisation.
    Dao Thi VL; Dreux M; Cosset FL
    Expert Rev Mol Med; 2011 Apr; 13():e13. PubMed ID: 21489334
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.
    Zibert A; Schreier E; Roggendorf M
    Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Single amino acid mutation of SR-BI decreases infectivity of hepatitis C virus derived from cell culture in a cell culture model.
    Gao R; Gao W; Xu G; Xu J; Ren H
    World J Gastroenterol; 2017 Jul; 23(28):5158-5166. PubMed ID: 28811710
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of HCV quasispecies in the hypervariable region 1 (HVR1) by in vitro translation and mass spectrometry.
    Yea C; Ayers M; Tellier R
    Methods Mol Biol; 2009; 510():73-81. PubMed ID: 19009254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus.
    Lavillette D; Pécheur EI; Donot P; Fresquet J; Molle J; Corbau R; Dreux M; Penin F; Cosset FL
    J Virol; 2007 Aug; 81(16):8752-65. PubMed ID: 17537855
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation.
    Mondelli MU; Cerino A; Lisa A; Brambilla S; Segagni L; Cividini A; Bissolati M; Missale G; Bellati G; Meola A; Bruniercole B; Nicosia A; Galfrè G; Silini E
    Hepatology; 1999 Aug; 30(2):537-45. PubMed ID: 10421665
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro interaction between hepatitis C virus (HCV) envelope glycoprotein E2 and serum lipoproteins (LPs) results in enhanced cellular binding of both HCV E2 and LPs.
    Wunschmann S; Muller HM; Stipp CS; Hemler ME; Stapleton JT
    J Infect Dis; 2006 Oct; 194(8):1058-67. PubMed ID: 16991080
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibodies directed to envelope proteins of hepatitis C virus outside of hypervariable region 1.
    Lechner S; Rispeter K; Meisel H; Kraas W; Jung G; Roggendorf M; Zibert A
    Virology; 1998 Apr; 243(2):313-21. PubMed ID: 9568031
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
    Pawlotsky JM; Pellerin M; Bouvier M; Roudot-Thoraval F; Germanidis G; Bastie A; Darthuy F; Rémiré J; Soussy CJ; Dhumeaux D
    J Med Virol; 1998 Apr; 54(4):256-64. PubMed ID: 9557291
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein.
    Heo TH; Lee SM; Bartosch B; Cosset FL; Kang CY
    Virus Res; 2006 Oct; 121(1):58-64. PubMed ID: 16725222
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1.
    Meunier JC; Engle RE; Faulk K; Zhao M; Bartosch B; Alter H; Emerson SU; Cosset FL; Purcell RH; Bukh J
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4560-5. PubMed ID: 15767578
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system.
    Lavie M; Voisset C; Vu-Dac N; Zurawski V; Duverlie G; Wychowski C; Dubuisson J
    Hepatology; 2006 Dec; 44(6):1626-34. PubMed ID: 17133472
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study of a novel hypervariable region in hepatitis C virus (HCV) E2 envelope glycoprotein.
    Troesch M; Meunier I; Lapierre P; Lapointe N; Alvarez F; Boucher M; Soudeyns H
    Virology; 2006 Sep; 352(2):357-67. PubMed ID: 16781757
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis C virus entry: potential receptors and their biological functions.
    Cocquerel L; Voisset C; Dubuisson J
    J Gen Virol; 2006 May; 87(Pt 5):1075-1084. PubMed ID: 16603507
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations.
    Prentoe J; Velázquez-Moctezuma R; Augestad EH; Galli A; Wang R; Law M; Alter H; Bukh J
    Proc Natl Acad Sci U S A; 2019 May; 116(20):10039-10047. PubMed ID: 31040211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.